64 Days
Source:
Lebanese Forces
Source: Lebanese Forces
64 DaysLebanese Forces
Source: Lebanese Forces
64 DaysReady to play
Ready to play
A new study has shown that the drug "Tirzepatide," known as "Mounjaro," may help in treating obstructive sleep apnea associated with obesity. Participants lost around 20% of their weight, and their episodes of apnea were significantly reduced. Researchers found that 42 to 50% of those affected were able to eliminate the condition, and weight loss is believed to be the main factor behind this improvement. However, the drug does not replace continuous positive airway pressure (CPAP) machines, which remain the primary treatment, especially in severe cases. The benefits of the medication are still uncertain after stopping its use, due to the possibility of weight regain.
Notice: This Is an AI-Generated Summary
Comments (0)